A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021

NCT01498497 · clinicaltrials.gov ↗

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: EUR-1100
DRUG: Placebo

Sponsor

Forest Laboratories